Zelluna is an innovative, exciting and growing company based in Oslo. Our vision is to transform cancer treatment and change the lives of patients. We are a highly dedicated and dynamic team with a continuous learning culture and bold ambitions. We are seeking highly engaged candidates that are inspired by our approach and motivated to help advance the company, shape the culture and make a difference to cancer patients. If you have a desire to join our team please refer to the current open positions or contact us at This email address is being protected from spambots. You need JavaScript enabled to view it..

08 August, 2018

Scientist – Cellular & Molecular Biology

Zelluna Immunotherapy is an exciting and dynamic start-up specializing in adoptive T cell therapies with a distinctive approach. The company has unique access to tumor specific T-cell receptors (TCRs) isolated from vaccinated patients who have shown remarkable long-term survival in late stage solid cancers. These TCRs recognise untapped class II as well as class I tumour associated antigens and so we believe the company portfolio provides differentiated therapeutic opportunities to drive transformative benefit to the lives of solid cancer patients.